Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Vaccine ; 30(9): 1659-66, 2012 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-22230585

RESUMO

Seasonal influenza causes more morbidity and mortality in older adults than in young adults, apparently because of a decline in immune function with increasing age, known as immunosenescence. In this study, we compared the capacity of dendritic cells (DCs) from healthy older adults (≥65 years) with DCs from healthy young adults (20-40 years) to initiate a T cell response against influenza. DCs from older adults were impaired in the induction of influenza-specific CD8+ T cells as compared to DCs from young adults, which was demonstrated by a decreased proliferation, an impaired production of IFN-γ and a reduced expression of the degranulation marker CD107a by CD8+ T cells. Importantly, DCs from older adults produced significantly less TNF-α, showed a decreased expression of HLA class I and had a lower maturation state after influenza virus infection. Supplementing TNF-α increased the expression of HLA class I and of maturation markers and enhanced the induction of the influenza-specific CD8+ T cell response. Together, these findings indicate that the impaired influenza-specific CD8+ T cell response in older adults is associated with a reduced production of TNF-α and with a lower DC maturation. We suggest that the production of TNF-α is a determining factor in the DC-mediated CD8+ T cell response against influenza.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Células Dendríticas/imunologia , Influenza Humana/imunologia , Fator de Necrose Tumoral alfa/metabolismo , Adulto , Fatores Etários , Idoso , Linfócitos T CD8-Positivos/virologia , Células Dendríticas/metabolismo , Feminino , Genes MHC Classe I , Humanos , Imunidade Celular , Vírus da Influenza A Subtipo H3N2 , Interferon gama/imunologia , Masculino , Proteínas Recombinantes/administração & dosagem , Fator de Necrose Tumoral alfa/administração & dosagem , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA